A specific and efficient promoter for buffalo skeletal muscle, its screening method and application

By screening and validating buffalo skeletal muscle-specific and highly efficient promoters, the 11bp-432bp upstream region of the VGLL2 gene was identified as the core promoter, which solved the problem of insufficient expression of exogenous genes in buffalo muscle and improved intramuscular fat deposition and meat quality in buffalo meat.

CN115851715BActive Publication Date: 2026-11-17GUANGXI UNIV
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202211049529.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-08-30
Publication Date
2026-11-17
Estimated Expiration
2042-08-30

AI Technical Summary

Technical Problem

Existing technologies make it difficult to achieve specific and efficient expression of exogenous genes in buffalo muscle tissue, resulting in buffalo meat quality being inferior to that of yellow cattle, especially due to insufficient intramuscular fat deposition, which affects the meat's flavor and texture.

Method used

We screened and validated buffalo skeletal muscle-specific and highly efficient promoters. By analyzing transcriptome data, qRT-PCR, and dual-luciferase reporter gene system, we identified the 11bp–432bp upstream region of the VGLL2 gene as the core promoter region, which can drive the efficient expression of exogenous genes in buffalo muscle.

Benefits of technology

It achieved specific and efficient expression of exogenous genes in buffalo muscle tissue, increased intramuscular fat deposition in buffalo meat, improved meat flavor and texture, and avoided increased fat deposition in other parts.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115851715B_ABST
    Figure CN115851715B_ABST
Patent Text Reader

Abstract

This invention belongs to the field of molecular biology technology, specifically relating to a buffalo skeletal muscle-specific and highly efficient promoter, its screening method, and its application. This invention obtains buffalo skeletal muscle-specific expression genes through high-throughput sequencing analysis and qRT-PCR. Based on buffalo genome sequences in the NCBI database, the upstream pseudo-promoter region of the gene is obtained, and primers are designed to obtain different truncated fragments. The buffalo skeletal muscle-specific and highly efficient promoter region is identified using a dual-luciferase reporter gene system. The buffalo skeletal muscle-specific and highly efficient promoter is shown in SEQ ID NO:1. This buffalo skeletal muscle-specific and highly efficient promoter can be applied to the efficient promotion of buffalo skeletal muscle-specific expression genes.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of molecular biology technology, specifically relating to a buffalo skeletal muscle-specific and highly efficient promoter, its screening method, and its application. Background Technology

[0002] A promoter is a base sequence on DNA located upstream of a structural gene and is a crucial component of the gene. Gene transcription is driven by the promoter; RNA polymerase recognizes and binds to the promoter sequence, regulating the transcription initiation process. As a cis-acting element, the promoter plays a vital role in gene expression regulation. The promoter itself cannot control gene expression; it needs to bind to specific transcription factors to exert its regulatory effect, determining the initiation site and frequency of gene transcription. Promoter activity refers to the ability of an organism to transcribe downstream genes into RNA, and it is influenced by factors such as cis-acting elements and trans-acting factors. In vivo, promoter elements are numerous and structurally complex; obtaining the correct promoter sequence and analyzing promoter activity are fundamental to the study of gene expression regulation.

[0003] In animal genetic improvement, to ensure the specific and efficient expression of the inserted exogenous target gene in muscle tissue, a muscle tissue-specific and efficient promoter sequence needs to be inserted upstream of the exogenous gene. my country possesses abundant water buffalo resources, historically primarily used for draft purposes. With the increasing mechanization of agriculture, the draft value of water buffalo has continuously declined, necessitating a shift towards meat production. However, water buffalo has poor intramuscular fat deposition, resulting in lower meat quality compared to cattle. Intramuscular fat significantly enhances the flavor, texture, and juiciness of meat. In production, the goal is to increase intramuscular fat deposition without affecting or even reducing fat deposition in other parts of the body, as fat deposition in other areas is considered wasteful. Therefore, screening and identifying specific and efficient promoters for water buffalo skeletal muscle is of great significance for the targeted improvement of water buffalo meat quality. Summary of the Invention

[0004] This invention discloses a specific and efficient promoter for buffalo skeletal muscle, its screening method, and its application, which can provide a powerful molecular tool for targeted improvement research on buffalo meat quality.

[0005] The present invention first provides a buffalo skeletal muscle-specific and highly efficient promoter, which is located in the region 11bp to 432bp upstream of the VGLL2 gene, and its sequence is shown in SEQ ID NO:1.

[0006] The specific primer pair for amplifying the above-mentioned buffalo skeletal muscle specific and efficient promoter is as follows: the upstream primer is 5'-CGGGGTACCCGAGCGCAGAGACTCTCCTT-3', as shown in SEQ ID NO:4, and the downstream primer is 5'-CCGCTCGAGCTCCCGCTAGTGGGCATTT-3', as shown in SEQ ID NO:5.

[0007] This invention also provides a method for screening the above-mentioned buffalo skeletal muscle-specific and highly efficient promoters, including the following:

[0008] We analyzed and screened buffalo skeletal muscle transcriptome sequencing datasets to obtain buffalo skeletal muscle-specific expression genes.

[0009] The gene specifically highly expressed in buffalo skeletal muscle was obtained by qRT-PCR.

[0010] Upstream sequences of candidate gene transcription start sites were obtained using buffalo genome sequences from the NCBI database. PCR primers were designed to clone pseudopromoters with different truncated fragments. The transcriptional activity of different truncated fragments was detected using a dual-luciferase reporter gene system, and finally, buffalo skeletal muscle-specific and highly efficient promoters were obtained.

[0011] Specifically, the following steps are included:

[0012] Step 1: Analyze and screen the buffalo skeletal muscle transcriptome sequencing dataset to obtain 12 genes that are specifically highly expressed in buffalo muscle, namely CACNG1, CACNG6, MYOG, VGLL2, MYOD1, KCNA7, DUPD1, PRR32, IGFN1, ACTN3, PITX3, and MURC.

[0013] Step 2: qRT-PCR was used to detect the expression levels of 12 candidate genes in different developmental stages (fetal cattle, calves, and adult cattle) and different tissues and organs (myocardium, liver, spleen, lung, kidney, and longissimus dorsi muscle) of buffalo. At the same time, the expression levels of candidate genes in the transcription sequencing data were combined to identify VGLL2 and CACNG1 as the buffalo skeletal muscle-specific high-expression genes.

[0014] Step 3: Based on the upstream sequences of the buffalo VGLL2 and CACNG1 genes in the NCBI (National Center for Biotechnology Information) database, design PCR cloning primers for different truncated fragments of the proposed promoter region.

[0015] Step 4: Extract buffalo genomic DNA and use PCR to clone nine different truncated fragments of the upstream pseudopromoter region of the buffalo skeletal muscle-specific high-expression genes VGLL2 and CACNG1.

[0016] Step 5: Different truncated fragments of the upstream proposed promoter regions of VGLL2 and CACNG1 were ligated into the pGL3-Basic vector, and a total of 9 pGL3-Basic recombinant plasmids were constructed. The pGL3-Basic recombinant plasmid sequences were verified to be correct by sequencing.

[0017] Step 6: Resuscitate and culture mouse myoblasts and buffalo skeletal muscle cells. Using firefly luciferase progenitor vector pGL3-Basic and Renilla luciferase reporter gene vector pRL-TK as negative controls, mouse myoblasts and buffalo skeletal muscle cells were co-transfected with the pGL3-Basic recombinant plasmid and the Renilla luciferase reporter gene vector pRL-TK.

[0018] Step 7: Collect cells transfected for 48 hours and detect the fluorescence values ​​of firefly and sea urchin in each group.

[0019] Step 8: Data analysis revealed that the core promoter region of the buffalo skeletal muscle-specific high-expression gene is the region 11bp to 432bp upstream of the VGLL2 gene. The specific promoter sequence is shown in SEQ ID NO:1.

[0020] The activity values ​​of firefly luciferase and Renilla luciferase after co-transfection of mouse myoblasts or buffalo skeletal muscle cells with the pGL3-Basic recombinant plasmid and the Renilla luciferase reporter gene vector pRL-TK were analyzed. The promoter activity was represented by the ratio of firefly luciferase activity to Renilla luciferase activity, i.e., the relative activity value. The significant difference analysis performed by GraphPadPrism software showed that the relative activity value of mouse myoblasts and buffalo skeletal muscle cells after co-transfection with the pGL3-Basic recombinant plasmid containing the 11bp-432bp upstream region of the VGLL2 gene and the Renilla luciferase reporter gene vector pRL-TK was the highest, i.e., the promoter activity was the highest. Therefore, the core promoter region of the buffalo skeletal muscle-specific high-expression gene was selected as the 11bp-432bp upstream region of the VGLL2 gene.

[0021] The beneficial effects of this invention are as follows:

[0022] The invention provides a buffalo skeletal muscle-specific and highly efficient promoter that can be applied to the specific and efficient expression of exogenous target genes in buffalo muscle tissue. Attached Figure Description

[0023] Figure 1 The graph shows the expression levels of 12 candidate genes detected by qRT-PCR in different developmental stages and different tissues and organs of buffalo.

[0024] Figure 2Transcriptome sequencing expression analysis of four candidate genes: CACNG1, VGLL2, PRR32, and MURC.

[0025] Figure 3 Agarose gel electrophoresis images of PCR clones of different truncated fragments of the proposed promoter region.

[0026] Figure 4 This is a graph showing the activity analysis of different truncated pseudopromoter fragments of CACNG1.

[0027] Figure 5 This is a graph showing the activity analysis of different truncated pseudopromoter fragments of VGLL2.

[0028] Figure 6 Verification analysis diagram of the proposed promoter fragments for CACNG1-532 and VGLL2-581.

[0029] Figure 7 Verification analysis diagram of the proposed promoter fragments for CACNG1-532 and VGLL2-422. Detailed Implementation

[0030] The present invention will now be described in more detail through specific embodiments to facilitate understanding of the technical solution of the present invention, but this is not intended to limit the scope of protection of the present invention.

[0031] Example 1: Screening for genes specifically overexpressed in buffalo skeletal muscle

[0032] First, the buffalo skeletal muscle transcriptome sequencing dataset (Huang J, Feng X, Zhu R, et al. Comparative transcriptome analysis reveals that PCK1 is a potential gene affecting IMF deposition in buffalo[J]. BMC Genomics, 2020, 21(1): 710.) was analyzed, and 12 genes highly expressed in buffalo muscle were screened out, namely CACNG1, CACNG6, MYOG, VGLL2, MYOD1, KCNA7, DUPD1, PRR32, IGFN1, ACTN3, PITX3, and MURC.

[0033] Then, based on the reference sequences of 12 genes in the NCBI database (CACNG1 (Gene ID: 102412641), CACNG6 (Gene ID: 102396600), MYOG (Gene ID: 102401463), VGLL2 (Gene ID: 102390959), MYOD1 (Gene ID: 102403268), KCNA7 (Gene ID: 102390575), DUPD1 (Gene ID: 102394986), PRR32 (Gene ID: 102400419), IGFN1 (Gene ID: 102407757), ACTN3 (Gene ID: 102412732), PITX3 (Gene ID: 102390286), MURC (Gene ID: 102390286), ... ID:102408225)) Designed qRT-PCR primers for qRT-PCR validation and screening of genes specifically highly expressed in buffalo skeletal muscle. Primer sequences are as follows:

[0034]

[0035] Next, total RNA was extracted from the myocardium, liver, spleen, lung, kidney, and longissimus dorsi muscle of six buffaloes (including fetal buffalo, 6-month-old buffalo, 1-year-old buffalo, 2-year-old buffalo, 3-year-old buffalo, and 4-year-old buffalo; tissue samples were collected from the Guangxi Buffalo Research Institute) using the Trizol method. The RNA was then reverse transcribed into cDNA using the Takara reverse transcription kit.

[0036] qRT-PCR was used to detect the expression levels of the above 12 candidate genes in the myocardium, liver, spleen, lung, kidney, and longissimus dorsi muscle of six buffaloes. The results are as follows: Figure 1 As shown. Data analysis identified CACNG1, VGLL2, PRR32, and MURC as highly expressed genes in buffalo skeletal muscle. This was further supported by transcriptome sequencing analysis of the expression of these genes (e.g., [example data]). Figure 2 As shown in the figure, the genes specifically highly expressed in buffalo skeletal muscle were identified as VGLL2 and CACNG1.

[0037] Example 2: Construction of Recombination Vectors with Different Truncated Fragments in the Proposed Starter Region

[0038] 1. Genomic DNA extraction

[0039] Buffalo muscle tissue was harvested, and buffalo genomic DNA was extracted using the phenol-chloroform extraction method. The extracted DNA was then stored at -20°C for later use. The detailed extraction process for buffalo genomic DNA is as follows:

[0040] (1) Take 0.1g of buffalo muscle tissue, add 600μL of tissue lysis buffer (0.5% SDS, 10mmol / L EDTA, 10mmol / L Tris-HCl, 150mmol / L NaCl), 20μL of proteinase K solution, and incubate at 56℃ until no tissue fragments are formed.

[0041] (2) Add 600 μL of equilibrated phenol solution, place it on a vertical mixing rotary apparatus, mix at 30 r for 15-30 min, and then centrifuge at 12000 r / min for 10 min.

[0042] (3) Take the supernatant and add 300 μL of equilibrated phenol and 300 μL of chloroform. Place it on a vertical mixing rotary apparatus and mix at 30 r for 10-20 min. Then centrifuge at 12000 r / min for 10 min.

[0043] (4) Take the supernatant and add 600 μL of chloroform. Place it on a vertical mixing rotator and mix for 10-20 min at 30 r. Then centrifuge at 12000 r / min for 10 min.

[0044] (5) Transfer the supernatant to a centrifuge tube, add 1 / 10 volume of sodium acetate solution, mix well, add 2 volumes of pre-cooled anhydrous ethanol, shake well, and you can observe flocculent DNA precipitate. Centrifuge at 12000 r / min for 10 min and remove the supernatant.

[0045] (6) Add 1 ml of freshly prepared 75% anhydrous ethanol to the DNA precipitate for washing, centrifuge at 12000 r / min for 3 min, discard the supernatant, and repeat the operation once. Dry with a strong airflow, dissolve in double-distilled water, and store at -20℃ for later use.

[0046] 2. Design and synthesis of PCR cloning primers for different truncated fragments of the proposed promoter region

[0047] Based on the upstream sequences of the buffalo VGLL2 gene (as shown in SEQ ID NO:2) and the CACNG1 gene (as shown in SEQ ID NO:3) from the NCBI (National Center for Biotechnology Information) database, PCR cloning primers for different truncated fragments of the proposed promoter region were designed using the primer design software Premier 5.0. A Kpn1 restriction site (5'-CGGGGTACC-3') was added to the 5' end of the upstream primer sequence, and an Xho1 restriction site (5'-CCGCTCGAG-3') was added to the 5' end of the downstream primer sequence. Primer sequence information is as follows:

[0048]

[0049]

[0050] 3. Cloning and recovery of different truncated fragments in the proposed promoter region

[0051] The synthesized upstream and downstream primer powders were briefly centrifuged, diluted to 10 μM with an appropriate amount of double-distilled water, and vortexed to mix thoroughly to ensure complete dissolution. Using extracted buffalo genomic DNA as a template, the optimal annealing temperature of the primers was determined. The reaction mixture consisted of: 1.0 μL buffalo genomic DNA; 0.2 μL upstream primer; 0.2 μL downstream primer; 5.0 μL 2×TaqPCR MasterMix; and 3.6 μL ddH2O. The reaction procedure is as follows:

[0052] Denaturation at 95℃ for 5 minutes;

[0053] 95℃ denaturation for 30s, 60℃ annealing for 30s, 72℃ extension for 1min, (35 cycles);

[0054] Extend at 72℃ for 10 minutes;

[0055] Store at 4℃.

[0056] Following the optimal annealing temperature of the primers, PCR cloning was performed using the Takara high-fidelity enzyme amplification system. The reaction mixture consisted of: 10 μL of 5×PrimeSTAR GXL Buffer; 4 μL of dNTP Mixture; 1 μL of upstream primer; 1 μL of downstream primer; 200 ng of genomic DNA; 2 μL of PrimeSTAR GXL DNA Polymerase; and ddH2O to a final volume of 50 μL. The reaction procedure is as follows:

[0057] Denature at 95℃ for 10 minutes;

[0058] 98℃ denaturation for 10s, 60℃ annealing for 15s, 68℃ extension for 30s, (35 cycles);

[0059] Extend at 68℃ for 5 minutes;

[0060] Store at 4℃.

[0061] Different truncated fragments of the pseudopromoter region obtained by PCR cloning, such as Figure 3 As shown.

[0062] PCR clones were recovered using the Tiangen Universal DNA Purification and Recovery Kit, yielding different truncated fragments of the proposed promoter region. The obtained PCR products were double-digested with restriction endonucleases Kpn1 and Xho1. The reaction mixture consisted of: 200 ng PCR product, 1 μL QuickCut Kpn1, 1 μL QuickCut Xho1, 3 μL 10×QuickCut Buffer, and ddH2O to a final volume of 30 μL. The double-digested truncated fragments of the proposed promoter region were then recovered using the Tiangen Universal DNA Purification and Recovery Kit and stored at -20℃ for later use.

[0063] 4. Linearization and recovery of firefly luciferase reporter gene vector pGL3-Basic

[0064] Prepare LB broth containing Amp+ and culture the pGL3-Basic vector culture overnight on a shaker at 37°C and 200 rpm. Extract the pGL3-Basic vector plasmid using the Tiangen plasmid mini-extraction kit. Double digest the obtained pGL3-Basic vector plasmid with restriction endonucleases Kpn1 and Xho1. The reaction mixture consisted of 1 μg pGL3-Basic plasmid, 1 μL QuickCut Kpn1, 1 μL Xho1, 5 μL 10×Cut Buffer, and ddH2O to a final volume of 50 μL. Incubate at 37°C for 2 hours. Recover the linearized pGL3-Basic vector plasmid according to the Tiangen universal DNA purification and recovery kit instructions and store at -20°C for later use.

[0065] 5. Ligation of different truncated fragments of the proposed promoter region with the linearized pGL3-Basic vector

[0066] Different truncated fragments of the double-digested promoter region were ligated to the linearized pGL3-Basic vector using T4 Ligase (Takara) overnight in a 16°C water bath. The ligation system was as follows: the mass ratio of the linearized pGL3-Basic vector to the different truncated fragments of the double-digested promoter region was 1:7, 1 μl of 1×T4 DNA Ligase, 1 μl of 10×T4 DNA Ligase Buffer, and ddH2O to a final volume of 10 μl.

[0067] 6. Transformation

[0068] Take 50 μl of competent DH5α cells (purchased from Novizan) and thaw them on ice. Add the ligation product to the competent DH5α cells, gently pipette to mix, place on ice for 30 min, heat shock in a 42°C water bath for 45 sec, place on ice for 5 min, add 900 μl of LB broth without antibiotics, and incubate at 37°C on a shaker at 200 rpm for 1 h. Centrifuge at 3000 rpm for 5 min, discard 800 μl of supernatant, pipette to mix, and spread the entire bacterial culture evenly onto LB solid medium plates containing Amp+ resistance. Incubate in an inverted 37°C incubator for 12 h.

[0069] 7. Identification of recombinant reporter gene vectors

[0070] A single, round colony was picked from an LB agar plate and placed into LB medium containing Amp+. The colony was cultured at 37°C and 200 rpm on a shaker for expansion. PCR amplification was performed to verify the colony's size. The PCR products were detected by agarose gel electrophoresis. The corresponding bacterial cultures with the correct fragment size were sequenced. Sequencing data comparison confirmed successful construction of the recombinant reporter gene vector. The plasmid was extracted for subsequent experiments, and the bacterial cultures were stored at -80°C for later use.

[0071] Example 3: Screening of core promoter regions of buffalo skeletal muscle-specifically overexpressed genes using a dual-luciferase reporter gene system 1. Cell culture and transfection

[0072] Mouse myoblasts (C2C12 cells) and buffalo skeletal muscle cells were thawed and cultured, and the cells were seeded into 48-well plates. When the cells reached 60% confluence, firefly luciferase progenitor vector pGL3-Basic and Renilla luciferase reporter gene vector pRL-TK were used as negative controls. pGL3-Basic recombinant plasmids and pRL-TK plasmids were co-transfected with Lipofectamine 3000 (Invitrogen). The total amount of DNA transfected per well was 0.4 μg, and the mass ratio of pGL3-Basic recombinant plasmids to pRL-TK vector was 25:1. Three replicates were set up for each group.

[0073] The specific procedures for plasmid transfection are as follows: Take two 1.5 mL centrifuge tubes for each group, and add 90 μL of serum-free culture medium to each tube. Add 46.2 ng of pRL-TK plasmid and 1153.8 ng of the corresponding co-transfected pGL3-Basic recombinant plasmid to one of the centrifuge tubes, along with 3 μL of P3000... TM Add reagents and mix well; add 3 μL of Lipofectamine 3000 reagent to another centrifuge tube and mix well; incubate the mixture in the two centrifuge tubes at room temperature for 5 min, mix them and incubate at room temperature for 20 min, add 60 μL of the mixture to each well, and then place the 48-well cell culture plate in a 37°C incubator for 48 h.

[0074] 2. Dual fluorescence assay

[0075] After 48 hours of transfection, discard the culture medium and wash twice with PBS. Add 65 μL of PLB cell lysis buffer to each well, lyse thoroughly for 20 minutes, then pipette the cell lysis buffer to mix well and collect the cells.

[0076] Follow the Dual-Lueiferase@Reporter Assay System instructions to detect luciferase activity on a microplate reader. Add 5 μL of collected cell samples to each well of a 96-well microplate, and add 25 μL of luciferase assay reagent II (LARII) to each well. Mix well by pipetting. Place the 96-well microplate in the microplate reader and measure the fluorescence value of fireflies, then save the data. Remove the microplate, add 25 μL of Stop & Go Mix reagent to each well to quench the reaction, and simultaneously start the Renida luciferase reaction. Measure the Renida fluorescence value and save the data.

[0077] Using the relative fluorescence activity of the firefly luciferase precursor vector pGL3-Basic as a negative control, the relative fluorescence activity of mouse C2C12 cells and buffalo skeletal muscle cells were compared after transfection with vectors containing different truncated promoter fragments of the CACNG1 gene. Figure 4 It was found that the CACNG1-532 promoter fragment exhibited the highest activity. Using the relative fluorescence activity of the firefly luciferase precursor vector pGL3-Basic as a negative control, the relative fluorescence activity of mouse C2C12 cells and buffalo skeletal muscle cells after transfection with vectors containing different truncated promoter fragments of the VGLL2 gene was compared. Figure 5 It was found that the VGLL2-581 promoter fragment exhibited the highest activity. Then, using the relative fluorescence activity of the firefly luciferase precursor vector pGL3-Basic as a negative control, the relative fluorescence activity of recombinant vectors containing CACNG1-532 and VGLL2-581 promoter fragments after transfection into mouse C2C12 cells and buffalo skeletal muscle cells were compared. It was concluded that the VGLL2-581 promoter fragment exhibited the highest activity. Figure 6 ).

[0078] To further determine the core promoter region of the VGLL2 gene, a proposed promoter fragment, VGLL2-422, was constructed. Using the relative fluorescence activity of the firefly luciferase precursor vector pGL3-Basic as a negative control, the relative fluorescence activity of recombinant vectors containing CACNG1-532 and VGLL2-422 proposed promoter fragments after transfection into mouse C2C12 cells and buffalo skeletal muscle cells was compared. The results showed that the VGLL2-422 proposed promoter fragment exhibited the highest activity. Figure 7The core promoter region of the buffalo skeletal muscle-specific high-expression gene was ultimately determined to be the 11bp–432bp upstream region of the VGLL2 gene, with the following base sequence:

[0079] 5'-CGAGCGCAGAGACTCTCCTTCACCTCGTCACCCTGGATGCACACGCTCAATTCTCCACTGTGAGGTCGGGGCTCTCCCCAAAGACCCTTCTCCACCACGCCACAACTTCCTCTCTCCAAATGTAAGATCCCCGGTTCCTCCCTCCTCTCCGTCCTCCTGTCCCTCCGGCGTTAGCCTGGAAAATCCCTAGTCCTCAACGGTGCGAAGTC TCAGCGCTCAAATTCCGGGCTGCGCAGGTCGCATAGGCTCGCCGCCGGGTGTCCAGGGAAAACGCACCGGCAGCCCCTCGGTCCCTAGTCCCTCTCACTCCATTGGCCCCCCGGTCCCCGCCCCCGACGCCCCCCTCCCCGCCTCTGCGGCTCAGGAGTGGCGTCAGCACGCCTGCCCCGCGTGGGGTTTAAATGCCCACTAGCGGGAG-3'.

[0080] The embodiments described above are merely preferred embodiments of the present invention and are not intended to limit the scope of the present invention. Therefore, all equivalent changes or modifications made to the structure, features and principles described in the claims of the present invention should be included within the scope of the present invention.

Claims

1. A buffalo skeletal muscle-specific and highly efficient promoter, characterized in that, The sequence of the promoter is shown in SEQ ID NO:

1.

2. A recombinant vector containing the buffalo skeletal muscle-specific and highly efficient promoter as described in claim 1.

3. The specific primer pair for amplifying the buffalo skeletal muscle-specific and highly efficient promoter as described in claim 1, characterized in that, The upstream primer is: 5'-CGGGGTACCCGAGCGCAGAGACTCTCCTT-3'; The downstream primer is: 5'-CCGCTCGAGCTCCCGCTAGTGGGCATTT-3'.

4. The application of the buffalo skeletal muscle-specific and highly efficient promoter as described in claim 1 in the expression of exogenous target genes in buffalo skeletal muscle.

5. The application according to claim 4, characterized in that, The exogenous target gene is VGLL2 .

Citation Information

Patent Citations

  • Identification of isolation cloning and core region of promoters suitable for gene expression of skeletal muscles in pigs

    CN101979547A